Search research articles
Contact Us
Filters
Showing results (1-10 of 38) with videos related to
Page
of 4
Sort By:
Ugeskrift for Laeger
|
October 28, 2021
[Lymphoid malignancy diagnostics]
Judit Jørgensen, Peter Kamper, Francesco d'Amore
Ugeskrift for Laeger
|
October 28, 2021
[Lymphoid malignancy treatment]
Judit Jørgensen, Peter Kamper, Francesco d'Amore
Case Reports in Hematology
|
January 20, 2022
Salvage Therapy in Early Relapse of T-Lymphoblastic Leukemia/Lymphoma Using Daratumumab/Nelarabine Combination: Two Consecutive Cases
Ingolf Molle, Irma Petruskevicius, Peter Kamper, et al.
Intensive Care Medicine
|
February 20, 2020
One-year mortality among non-surgical patients with hematological malignancies admitted to the intensive care unit: a Danish nationwide population-based cohort study
Peter H Asdahl, Steffen Christensen, Anders Kjærsgaard, et al.
Leukemia & Lymphoma
|
October 3, 2018
The incidence of bleomycin induced lung toxicity is increased in Hodgkin lymphoma patients over 45 years exposed to granulocyte-colony stimulating growth factor <sup>†</sup>
Maja D Andersen, Peter Kamper, Alexander d'Amore, et al.
Hematology Reports
|
January 21, 2026
Paraneoplastic Neuro-Ophthalmologic Symptoms as Initial Manifestation of Hodgkin Lymphoma
Sophie-Charlott Seidenfaden, Thomas Graversgaard Adams, Peter Kamper, et al.
Haematologica
|
November 13, 2010
Tumor-infiltrating macrophages correlate with adverse prognosis and Epstein-Barr virus status in classical Hodgkin's lymphoma
Peter Kamper, Knud Bendix, Stephen Hamilton-Dutoit, et al.
Cancers
|
January 11, 2022
Classic Hodgkin Lymphoma Refractory for ABVD Treatment Is Characterized by Pathologically Activated Signal Transduction Pathways as Revealed by Proteomic Profiling
Bent Honoré, Maja Dam Andersen, Diani Wilken, et al.
European Journal of Haematology
|
March 15, 2021
Soluble programmed cell death protein 1 (sPD-1) and the soluble programmed cell death ligands 1 and 2 (sPD-L1 and sPD-L2) in lymphoid malignancies
Julie B Mortensen, Ida Monrad, Marie B Enemark, et al.
The British Journal of Ophthalmology
|
August 1, 2020
Ocular adnexal lymphoma in Denmark: a nationwide study of 387 cases from 1980 to 2017
Frederik Holm, Lauge Hjorth Mikkelsen, Peter Kamper, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 38) with videos related to
Sort By:
Page
of 4
Ugeskrift for Laeger
|
October 28, 2021
[Lymphoid malignancy diagnostics]
Judit Jørgensen, Peter Kamper, Francesco d'Amore
Ugeskrift for Laeger
|
October 28, 2021
[Lymphoid malignancy treatment]
Judit Jørgensen, Peter Kamper, Francesco d'Amore
Case Reports in Hematology
|
January 20, 2022
Salvage Therapy in Early Relapse of T-Lymphoblastic Leukemia/Lymphoma Using Daratumumab/Nelarabine Combination: Two Consecutive Cases
Ingolf Molle, Irma Petruskevicius, Peter Kamper, et al.
Intensive Care Medicine
|
February 20, 2020
One-year mortality among non-surgical patients with hematological malignancies admitted to the intensive care unit: a Danish nationwide population-based cohort study
Peter H Asdahl, Steffen Christensen, Anders Kjærsgaard, et al.
Leukemia & Lymphoma
|
October 3, 2018
The incidence of bleomycin induced lung toxicity is increased in Hodgkin lymphoma patients over 45 years exposed to granulocyte-colony stimulating growth factor <sup>†</sup>
Maja D Andersen, Peter Kamper, Alexander d'Amore, et al.
Hematology Reports
|
January 21, 2026
Paraneoplastic Neuro-Ophthalmologic Symptoms as Initial Manifestation of Hodgkin Lymphoma
Sophie-Charlott Seidenfaden, Thomas Graversgaard Adams, Peter Kamper, et al.
Haematologica
|
November 13, 2010
Tumor-infiltrating macrophages correlate with adverse prognosis and Epstein-Barr virus status in classical Hodgkin's lymphoma
Peter Kamper, Knud Bendix, Stephen Hamilton-Dutoit, et al.
Cancers
|
January 11, 2022
Classic Hodgkin Lymphoma Refractory for ABVD Treatment Is Characterized by Pathologically Activated Signal Transduction Pathways as Revealed by Proteomic Profiling
Bent Honoré, Maja Dam Andersen, Diani Wilken, et al.
European Journal of Haematology
|
March 15, 2021
Soluble programmed cell death protein 1 (sPD-1) and the soluble programmed cell death ligands 1 and 2 (sPD-L1 and sPD-L2) in lymphoid malignancies
Julie B Mortensen, Ida Monrad, Marie B Enemark, et al.
The British Journal of Ophthalmology
|
August 1, 2020
Ocular adnexal lymphoma in Denmark: a nationwide study of 387 cases from 1980 to 2017
Frederik Holm, Lauge Hjorth Mikkelsen, Peter Kamper, et al.
Page
of 4